Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment procures and distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of May 14, 2018, the company owned and operated approximately 800 patient care clinics in the United States. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolOTCMKTS:HNGR
CUSIP41043F20
Phone512-777-3800
Debt
Debt-to-Equity Ratio-14.28
Current Ratio1.86
Quick Ratio1.41
Price-To-Earnings
Trailing P/E Ratio50.30
Forward P/E Ratio20.24
P/E Growth2.02
Sales & Book Value
Annual Sales$1.04 billion
Price / Sales0.59
Cash Flow$1.6583 per share
Price / Cash10.01
Book Value($0.77) per share
Price / Book-21.56
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees4,600
Outstanding Shares36,800,000
Market Cap$609.03 million
Hanger (OTCMKTS:HNGR) Frequently Asked Questions
What is Hanger's stock symbol?
Hanger trades on the OTCMKTS under the ticker symbol "HNGR."
How were Hanger's earnings last quarter?
Hanger Inc (OTCMKTS:HNGR) posted its quarterly earnings data on Thursday, August, 9th. The healthcare company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by $0.05. The healthcare company had revenue of $266.97 million for the quarter, compared to the consensus estimate of $265.58 million. View Hanger's Earnings History.
When is Hanger's next earnings date?
What price target have analysts set for HNGR?
1 brokerages have issued 1-year target prices for Hanger's stock. Their forecasts range from $17.00 to $17.00. On average, they expect Hanger's share price to reach $17.00 in the next twelve months. This suggests a possible upside of 2.4% from the stock's current price. View Analyst Price Targets for Hanger.
What is the consensus analysts' recommendation for Hanger?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hanger in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Hanger.
Who are some of Hanger's key competitors?
Some companies that are related to Hanger include Spectrum Pharmaceuticals (SPPI), Akorn (AKRX), Supernus Pharmaceuticals (SUPN), Crispr Therapeutics (CRSP), Aphria (APH), Spark Therapeutics (ONCE), Integer (ITGR), Myokardia (MYOK), Nobel Biocare (NBHGF), Patterson Companies (PDCO), Xencor (XNCR), Acceleron Pharma (XLRN), CONMED (CNMD), Repligen (RGEN) and Momenta Pharmaceuticals (MNTA).
Who are Hanger's key executives?
Hanger's management team includes the folowing people:
- Mr. Vinit K. Asar, CEO, Pres & Director (Age 52)
- Mr. Thomas E. Kiraly, CFO & Exec. VP (Age 58)
- Mr. Thomas E. Hartman, Sr. VP, Gen. Counsel & Sec. (Age 55)
- Mr. Samuel M. Liang, Pres of Hanger Clinic (Age 55)
- Ms. Gabrielle B. Adams, VP & Chief Accounting Officer (Age 49)
Has Hanger been receiving favorable news coverage?
Media coverage about HNGR stock has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Hanger earned a daily sentiment score of 0.21 on Accern's scale. They also assigned media stories about the healthcare company an impact score of 45.53 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Hanger.
How do I buy shares of Hanger?
Shares of HNGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hanger's stock price today?
One share of HNGR stock can currently be purchased for approximately $16.60.
How big of a company is Hanger?
Hanger has a market capitalization of $609.03 million and generates $1.04 billion in revenue each year. The healthcare company earns $-104,670,000.00 in net income (profit) each year or $0.33 on an earnings per share basis. Hanger employs 4,600 workers across the globe.
How can I contact Hanger?
Hanger's mailing address is 10910 DOMAIN DRIVE SUITE 300, AUSTIN TX, 78758. The healthcare company can be reached via phone at 512-777-3800 or via email at [email protected]
MarketBeat Community Rating for Hanger (OTCMKTS HNGR)
MarketBeat's community ratings are surveys of what our community members think about Hanger and other stocks. Vote "Outperform" if you believe HNGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HNGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
